Vivus falls on expected CHMP negative opinion

Vivus Inc. (NASDAQ:VVUS) fell $2.72 (11%) to $21 on Friday after the company said it expects EMA's CHMP to

Read the full 193 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE